Fisetin Intervention Study in Mild Alzheimer's Disease
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Healthy Volunteers: f
View:
• Mild cognitive impairment due to Alzheimer's disease OR mild Alzheimer Dementia
• Moca score of 11 or higher
• Stable psychotropics and cognitive enhancing medications
Locations
Other Locations
Canada
Sunnybrook Research Institute
RECRUITING
Toronto
Contact Information
Primary
Study Coordinator
memoryresearch@sunnybrook.ca
416-480-6100
Time Frame
Start Date: 2026-01-27
Estimated Completion Date: 2026-11
Participants
Target number of participants: 5
Treatments
Experimental: Fisetin
Related Therapeutic Areas
Sponsors
Leads: Sunnybrook Health Sciences Centre
Collaborators: Sunnybrook Research Institute